Israel Englander Cardiff Oncology, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 152,685 shares of CRDF stock, worth $383,239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,685

Previous 239,609 36.28%

Holding current value

$383,239

Previous $531,000 23.35%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.05 - $2.77 $178,194 - $240,779	-86,924 Reduced 36.28%	152,685 $407,000
Q2 2024 Aug 14, 2024	SELL	$2.22 - $5.89 $984,991 - $2.61 Million	-443,690 Reduced 64.93%	239,609 $531,000
Q1 2024 May 15, 2024	BUY	$1.46 - $5.91 $997,616 - $4.04 Million	683,299 New	683,299 $3.65 Million
Q2 2023 Aug 14, 2023	SELL	$1.37 - $1.95 $75,628 - $107,645	-55,203 Reduced 53.11%	48,739 $71,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.09 $53,396 - $76,964	-36,825 Reduced 26.16%	103,942 $172,000
Q4 2022 Feb 14, 2023	SELL	$1.22 - $1.66 $72,004 - $97,973	-59,020 Reduced 29.54%	140,767 $197,000
Q3 2022 Nov 14, 2022	SELL	$1.54 - $3.21 $298,476 - $622,149	-193,816 Reduced 49.24%	199,787 $308,000
Q2 2022 Aug 15, 2022	BUY	$1.17 - $2.61 $127,072 - $283,469	108,609 Added 38.11%	393,603 $866,000
Q1 2022 May 16, 2022	SELL	$2.11 - $7.25 $282,499 - $970,673	-133,886 Reduced 31.96%	284,994 $707,000
Q4 2021 Feb 14, 2022	BUY	$5.18 - $7.24 $1.51 Million - $2.11 Million	291,382 Added 228.54%	418,880 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$5.01 - $7.58 $638,764 - $966,434	127,498 New	127,498 $849,000
Q2 2021 Aug 16, 2021	SELL	$6.65 - $10.04 $2.15 Million - $3.24 Million	-322,962 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.1 - $19.57 $2.65 Million - $5.69 Million	290,921 Added 907.96%	322,962 $2.99 Million
Q4 2020 Feb 16, 2021	SELL	$12.02 - $24.71 $744,182 - $1.53 Million	-61,912 Reduced 65.9%	32,041 $576,000
Q3 2020 Nov 16, 2020	BUY	$4.25 - $14.19 $399,300 - $1.33 Million	93,953 New	93,953 $1.33 Million

Others Institutions Holding CRDF

# of Institutions

Shares Held

12.3M

Call Options Held

813K

Put Options Held

91.1K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $109M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account